Digital health tools like telemedicine, AI algorithms, and connectivity are playing an increasingly important role in helping prevent and manage disease.
Companies aim to integrate Abbott's FreeStyle Libre glucose sensing with Tandem's insulin delivery products to expand choices for people with diabetes.
FDA is aware patients may choose to create these systems or purchase unauthorized or unapproved components or systems because of personal preference or cost.